Grégory Catteau, MSc

Statistician
GSK
Rixensart, Brabant Wallon, Belgium

Disclosure: GSK group of companies: Board Member

Presentation(s):

• 2905 - Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling

  Saturday, October 5
  4:15 PM – 4:30 PM